Several studies have reported that decreased function of E-cadherin is associated with tumour progression in many cancers, and in particular E-cadherin acts as a suppressor of invasive ability (Behrens et al, 1989; Vleminckx et al, 1991; Hirohashi, 2000). Here, CDH1 is linked to cancer.